ArticleMolecular therapy. Methods & clinical development2021

Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells.

Guido J J Kierkels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.